Last reviewed · How we verify

NCT04876976

Isoamyl 2-Cyanoacrylate in the Urethro-cutaneous Fistula Repair

Completed Phase 2, PHASE3 Last updated 7 May 2021
What this trial tests

Phase 2, PHASE3 trial testing Cyanoacrylate, Isobutyl in Hypospadias in 40 participants. Completed in 1 January 2020.

Timeline
1 January 2017
Primary endpoint
1 January 2020
1 January 2020

Quick facts

Lead sponsorAin Shams University
PhasePhase 2, PHASE3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date1 January 2017
Primary completion1 January 2020
Estimated completion1 January 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Eligibility, male only, with Hypospadias. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

cyanoacrylate has an impact that may aid in the successful repair of urethra-cutaneous fistula (UCF) that occur after hypospadias surgical repair

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Cyanoacrylate, Isobutyl

Trials testing the same drug.

Other recruiting trials for Hypospadias

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04876976.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing